PTC Therapeutics, Inc.: current liabilities
Current liabilities for PTC Therapeutics, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PTC Therapeutics, Inc. financial histories
What this measure means
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
Exact concept: us-gaap:LiabilitiesCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2012-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 968,427,000 | USD | 2026-02-19 | 10-K · 0001104659-26-017575 |
| At date | 2024-12-31 | 580,981,000 | USD | 2026-02-19 | 10-K · 0001104659-26-017575 |
| At date | 2023-12-31 | 603,100,000 | USD | 2025-02-27 | 10-K · 0001070081-25-000012 |
| At date | 2022-12-31 | 406,236,000 | USD | 2024-02-29 | 10-K · 0001558370-24-002196 |
| At date | 2021-12-31 | 509,348,000 | USD | 2023-02-21 | 10-K · 0001070081-23-000011 |
| At date | 2020-12-31 | 277,333,000 | USD | 2022-02-22 | 10-K · 0001070081-22-000011 |
| At date | 2019-12-31 | 235,857,000 | USD | 2021-02-25 | 10-K · 0001070081-21-000009 |
| At date | 2018-12-31 | 166,796,000 | USD | 2020-03-02 | 10-K · 0001070081-20-000064 |
| At date | 2017-12-31 | 82,048,000 | USD | 2019-03-01 | 10-K · 0001070081-19-000018 |
| At date | 2016-12-31 | 49,624,000 | USD | 2018-03-06 | 10-K · 0001070081-18-000042 |
| At date | 2015-12-31 | 45,386,000 | USD | 2017-03-16 | 10-K · 0001070081-17-000062 |
| At date | 2014-12-31 | 32,475,000 | USD | 2016-02-29 | 10-K · 0001047469-16-010589 |
| At date | 2013-12-31 | 13,134,000 | USD | 2015-03-02 | 10-K · 0001047469-15-001457 |
| At date | 2012-12-31 | 28,158,889 | USD | 2014-03-06 | 10-K · 0001047469-14-001914 |
Related financial histories
- PTC Therapeutics, Inc.: total assets
- PTC Therapeutics, Inc.: total liabilities
- PTC Therapeutics, Inc.: stockholders equity
- PTC Therapeutics, Inc.: cash and cash equivalents
- PTC Therapeutics, Inc.: net income or loss
- PTC Therapeutics, Inc.: operating cash flow
- PTC Therapeutics, Inc.: capital expenditure payments
- PTC Therapeutics, Inc.: contract revenue excluding tax
- PTC Therapeutics, Inc.: financing cash flow
- PTC Therapeutics, Inc.: investing cash flow
- PTC Therapeutics, Inc.: retained earnings or deficit
- PTC Therapeutics, Inc.: basic weighted-average shares
- PTC Therapeutics, Inc.: diluted weighted-average shares
- PTC Therapeutics, Inc.: basic earnings per share
- PTC Therapeutics, Inc.: diluted earnings per share
- PTC Therapeutics, Inc.: income tax expense or benefit
- PTC Therapeutics, Inc.: net property, plant and equipment
- PTC Therapeutics, Inc.: share-based compensation expense
- PTC Therapeutics, Inc.: operating income or loss
- PTC Therapeutics, Inc.: current assets
- PTC Therapeutics, Inc.: current accounts payable
- PTC Therapeutics, Inc.: goodwill carrying amount
- PTC Therapeutics, Inc.: net finite-lived intangible assets
- PTC Therapeutics, Inc.: operating expenses
- PTC Therapeutics, Inc.: net inventory
- PTC Therapeutics, Inc.: selling, general and administrative expense
- PTC Therapeutics, Inc.: research and development expense
Inspect the source
- Entity
- PTC Therapeutics, Inc. / CIK 0001070081
- Captured
- 2026-09-20T05:19:30.322Z
- SEC response SHA-256
d748041dc0149cc4539c2407042aaa6286795ec2b9d1722f0cb5484cca6764d4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001070081.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))